References
- Henry M, Sisler HD. Effects of sterol biosynthesis-inhibiting (SBI) fungicides on cytochrome P-450 oxygenations in fungi. Pestic Biochem Physiol 1984; 22: 262–275.
- Lamb DC, Kelly DE, Baldwin BC, et al. Differential inhibition of Candida albicans CYP51 with azole antifungal stereoisomers. FEMS Microbiol Lett 1997; 149: 25–30.
- Vanden Bossche H, Marichal P, Gorrens J, et al. Interaction of azole derivatives with cytochrome P-450 isoenzymes in yeast, fungi, plants and mammalian cells. Pestic Sci 1987; 21: 289–306.
- Takahashi H. New topical imidazoles under development in Japan. TJN-318 (NND-318): evaluation of antifungal activities and the results of clinical open study on dermatomycoses. In: Yamaguchi H, Kobayashi GS, Takahashi H, eds. Recent Pro-gress in Antifungal Chemotherapy. New York: Mercel Dekker Inc, 1991; 103–112.
- Niwano Y, Kuzuhara N, Kodama H, Yoshida M, Miyazaki T, Yamaguchi H. In vitro and in vivo antidermatophyte activities of NND-502 a novel optically active imidazole antimycotic agent. Antimicrob Agents Chemother 1998; 42: 967–970.
- Stettendorf S. Tolerability and efficacy of bifonazole in der-matomycoses. Arzneim-Forsch 'Drug Res 1983; 33: 750–754.
- Kodama H, Niwano Y, Kanai K, Yoshida M. Japanese patent (Jpn. Kokai Tokkyo Koho), H9-100279, April 1997.
- Seo A, Kanno H, Hasegawa N, Miyagi Y, Ikeda K. Japanese patent (Jpn. Kokai Tokkyo Koho), S60-218387, November 1985.
- Kato T, Kawase Y. Selective inhibition of demethylation at C-14 in ergosterol biosynthesis by the fungicide Denmert (5-1358). Agr Biol Chem 1976; 40: 2379–2388.
- Ryder NS, Seidl G, Troke P. Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albi-cans. Antimicrob Agents Chemother 1984; 25: 483–487.
- Guan J, de Waard MA. Inhibition of sterol 14cc-demethylase activity in Penicillium italicum does not correlate with resistance to the DMI fungicide imazalil. Pestic Biochem Physiol 1993; 46: 1–6.
- Yoshida Y, Aoyama Y. Interaction of azole antifungal agents with cytochrome P-45014DM purified from Saccharomyces cerevisiae microsomes. Biochem Pharmacol 1987; 36: 229–235.